Glioma), 35 (PCNSL vs
Glioma), 35 (PCNSL vs. supporting the diagnosis of PCNSL 1,2,3,4,5,6-Hexabromocyclohexane is suggested. = 67) by a shotgun proteomics approach and in the second step, we selected candidate biomarkers which were validated in an independent cohort (= 64; Table 1b and Table S1B) by targeted mass spectrometry using selected reaction monitoring (SRM) and immunohistochemistry. Table 1 […]